The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 16, 2018

Filed:

Apr. 27, 2016
Applicant:

Daewoong Pharmaceutical Co., Ltd., Gyeonggi-do, KR;

Inventors:

Chun Ho Lee, Seoul, KR;

Seung Chul Lee, Gyeonggi-do, KR;

Yeon Im Lee, Gyeonggi-do, KR;

Deok Ki Eom, Gyeonggi-do, KR;

Mi Ryeong Han, Gyeonggi-do, KR;

Eun Ji Koh, Gyeonggi-do, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 207/48 (2006.01); A61P 31/04 (2006.01); A61P 1/16 (2006.01);
U.S. Cl.
CPC ...
C07D 207/48 (2013.01); A61P 1/16 (2018.01); A61P 31/04 (2018.01);
Abstract

The present invention provides a 4-methoxy pyrrole derivative or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutical composition containing the same. The 4-methoxy pyrrole derivatives or pharmaceutically acceptable salts thereof according to the present invention have not only excellent proton pump inhibitory activity, gastric damage-inhibiting activity and defensive factor-enhancing effects, but also excellent eradication activity against. Therefore, the 4-methoxy pyrrole derivatives or pharmaceutically acceptable salts thereof can be effectively used for the prevention and treatment of gastrointestinal damage due to gastrointestinal tract ulcer, gastritis, reflux esophagitis or. Moreover, the 4-methoxy pyrrole derivatives or pharmaceutically acceptable salts thereof, have inhibitory activities against GPCR and thus can be effectively used for the prevention and treatment of 5-HT receptor-mediated or muscarinic acetylcholine receptor-mediated diseases.


Find Patent Forward Citations

Loading…